Britain to impose £2.20 per 10 ml tax on e‑liquids from 2027, spurring industry changes

The British government disclosed that a fresh Vaping Product Duty will commence in April 2027, imposing a charge of £2.20 per 10 ml of e‑liquid sold. As outlined in a recent BBC Business report, this represents the inaugural instance of a volume‑based tax on vaping products.

Officials argue the levy aims to tackle public‑health issues, especially the growing trend of youths trying e‑cigarettes. By matching the tax framework to that applied to alcohol and tobacco, the government seeks to curb casual consumption while preserving a less risky option for adult smokers.

Trade associations caution that the charge may markedly lift the cost of well‑known e‑liquid brands, possibly driving some users back to traditional cigarettes or into black‑market sources. Small producers, often operating on razor‑thin margins, foresee a steep rise in expenses that could compel consolidation or even market exit.

Consumer watchdogs point out that elevated prices might produce mixed outcomes. Though price hurdles could dissuade new, particularly younger, users, they may also impose a financial burden on adult vapers using e‑cigarettes to quit. The government has signalled that duty proceeds will be allocated to smoking‑cessation initiatives, though specifics are still being debated.

Analysts draw parallels between the forthcoming levy and previous UK tobacco tax increases, which historically reduced smoking prevalence yet encouraged illicit trade. Monitoring systems are slated to detect any surge in illegal e‑liquid sales, and the Treasury has stressed that enforcement will be a focus.

With the April 2027 rollout drawing near, retailers are tweaking stock levels and pricing tactics. Certain sellers are pushing higher‑strength liquids, which could attract a lower effective tax per nicotine milligram, while others are looking at alternative offerings like heated‑tobacco devices that escape the present duty scope. The next months should show how the sector adjusts to the new fiscal terrain and if the projected public‑health benefits materialise.